Enfortumab vedotin is often combined with the immunotherapy drug pembrolizumab to treat advanced bladder cancer. While lifestyle changes can’t help treat bladder cancer, some adjustments can ...

Bladder cancer primarily affects individuals over ... Those who are taking more than one immunotherapy drug, referred to as combination therapy, are at an increased risk of experiencing side ...

It’s an immunotherapy drug. Chemotherapy is a type of cancer ... tried chemotherapy and at least one other therapy. Bladder cancer: Keytruda is prescribed to adults to treat bladder cancer ...

R esults from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time ...

Cytotoxic T lymphocytes may allow us to expand the usage of immunotherapy to treat advanced bladder cancer. Bladder cancer serves as a model malignancy by which existing treatments can be improved ...

The US regulator has approved AstraZeneca’s cancer immunotherapy ... generated by selling off older or unwanted drugs. While the approval in bladder cancer is a good start for durvalumab ...

Recent analysis from the National Cancer Database (NCDB) reveals a significant uptick in immunotherapy (IO) use for advanced ...

“It is very exciting that we have now identified a combination of treatments that ... of chemotherapy and immunotherapy in patients with metastatic bladder cancer,” said Dr Apolo, who noted ...

They include chemotherapy, radiation therapy, immunotherapy and targeted therapy ... from Fred Hutchinson Cancer Center and UW Medicine are testing new treatments for bladder cancer and other cancers ...

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free ...

These treatments ... and invasive bladder cancer is becoming more sophisticated daily as we gain knowledge of the behavior of these cancers, identifying new targets for therapy and improving surgical ...